Neurotech, Neuromodulation, Alzheimers.
non-pain-relief conditions such as Parkinson’s or epilepsy. But treatments for those types of conditions tend to be more the province of smaller medical technology companies, with market caps more in the $10 million to $100 million range. (See A Guide to the Neuromodulation Market.) And until